Amgen

Recent news

• Company notice
  Amgen | 4: Statement of changes in beneficial ownership of securities-Officer Busch Matthew C.
  SEC · 2026/5/12
• Cantor Fitzgerald Maintains Amgen(AMGN.US) With Hold Rating, Raises Target Price to $440
  Market Newswire · 2026/10/8
• Rating change
  Scotiabank Maintains Amgen(AMGN.US) With Buy Rating, Maintains Target Price $500
  Market Newswire · 2026/9/29
• Rating change
  Scotiabank Maintains Amgen(AMGN.US) With Buy Rating, Raises Target Price to $500
  Market Newswire · 2026/9/29
• Rating change
  Truist Financial Maintains Amgen(AMGN.US) With Hold Rating
  Market Newswire · 2026/9/24
• Company notice
  Amgen | 3: Initial statement of beneficial ownership of securities- Dittrich Thomas J.W.
  SEC · 2026/9/5
• Wells Fargo Maintains Amgen(AMGN.US) With Hold Rating, Maintains Target Price $435
  Market Newswire · 2026/10/2
• Rating change
  A Quick Look at Today's Ratings for Amgen(AMGN.US), With a Forecast Between $380 to $457
  Market Newswire · 2026/9/18
• RBC Capital Maintains Amgen(AMGN.US) With Buy Rating, Raises Target Price to $430
  Market Newswire · 2026/10/8
• Company notice
  Amgen | 4: Statement of changes in beneficial ownership of securities-Officer Grygiel Nancy A.
  SEC · 2026/5/12
• Rating change
  Goldman Sachs Maintains Amgen(AMGN.US) With Buy Rating, Maintains Target Price $450
  Market Newswire · 2026/9/23
• Company notice
  Amgen | 4: Statement of changes in beneficial ownership of securities-Director Klotman Mary E.
  SEC · 2026/5/22
• Rating change
  A Quick Look at Today's Ratings for Amgen(AMGN.US), With a Forecast Between $317 to $457
  Market Newswire · 2026/9/23
• Rating change
  Analysts Have Conflicting Sentiments on These Healthcare Companies: Sanofi (OtherSNYNF), Amgen (AMGN) and BrightSpring Health Services, Inc. (BTSG)
  TipRanks · 2026/9/17
• Rating change
  Scotiabank Maintains Amgen(AMGN.US) With Buy Rating, Maintains Target Price $450
  Market Newswire · 2026/9/24
• Rating change
  Raymond James Maintains Amgen(AMGN.US) With Hold Rating
  Market Newswire · 2026/9/25
• Rating change
  Wells Fargo Maintains Amgen(AMGN.US) With Hold Rating, Raises Target Price to $435
  Market Newswire · 2026/9/22
• Piper Sandler Maintains Amgen(AMGN.US) With Buy Rating, Maintains Target Price $457
  Market Newswire · 2026/10/5
• UBS Maintains Amgen(AMGN.US) With Buy Rating, Raises Target Price to $470
  Market Newswire · 2026/10/9
• Company notice
  Amgen | 4: Statement of changes in beneficial ownership of securities-Director Garland Greg C.
  SEC · 2026/5/22
• Rating change
  Piper Sandler Maintains Amgen(AMGN.US) With Buy Rating, Maintains Target Price $457
  Market Newswire · 2026/9/23
• Rating change
  A Quick Look at Today's Ratings for Amgen(AMGN.US), With a Forecast Between $317 to $452
  Market Newswire · 2026/9/9
• Rating change
  BMO Capital Downgrades Amgen(AMGN.US) to Hold Rating, Maintains Target Price $450
  Market Newswire · 2026/9/8
• Rating change
  Citi Maintains Amgen(AMGN.US) With Hold Rating, Maintains Target Price $405
  Market Newswire · 2026/9/9
• Rating change
  TD Cowen Maintains Amgen(AMGN.US) With Buy Rating, Maintains Target Price $452
  Market Newswire · 2026/8/27

Headlines are aggregated automatically and are not independently verified or edited by our team.